Sunday, September 17, 2017 10:49:11 AM
As I said, I don't think it means profitability is pushed back 6 months. Of course, it's confusing, so we're not sure. We definitely need Nigeria for the original timeline to not be pushed back.
I would not call it "cash problems", even if we do only have Kenya (which shouldn't be the case). As long as these purchase orders start flowing in as they are contracted to do so, the debt will be eliminated in a relatively short amount of time. Compared to the debt that other biotechs can generate in their startup phase, I think we're doing well here. This will be a very significant revenue channel, and under $10m debt is pretty good IMO.
Avant Technologies Engages Wired4Tech to Evaluate the Performance of Next Generation AI Server Technology • AVAI • May 23, 2024 8:00 AM
Branded Legacy, Inc. Unveils Collaboration with Celebrity Tattoo Artist Kat Tat for New Tattoo Aftercare Product • BLEG • May 22, 2024 8:30 AM
"Defo's Morning Briefing" Set to Debut for "GreenliteTV" • GRNL • May 21, 2024 2:28 PM
North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM